Literature DB >> 8488838

Neurobehavioral effects of the fragile X premutation in adult women: a controlled study.

A L Reiss1, L Freund, M T Abrams, C Boehm, H Kazazian.   

Abstract

Although previous studies have suggested that the fragile X premutation (fra [X] pM) does not cause deleterious effects, methodological constraints have prevented more definitive conclusions from being reached. In this report, we describe the neuropsychiatric and cognitive-neuropsychological status of 34 adult women with the fra (X) pM, as compared with a well-matched control group of 41 mothers of fra (X)-negative children with developmental disability. The results indicate that there are no meaningful differences between adult women with the fra (X) pM and control subjects with respect to cognitive abilities or profile, neuropsychological function, psychiatric diagnoses or symptoms, and self-rated personality profile. No measure for either group showed evidence of functioning outside the normal range except for a high lifetime prevalence of major depression in both groups. Additional exploratory analyses within the fra (X) group showed no significant effect of either the size of the fra (X) insert or X chromosome inactivation pattern in leukocytes, on any measure of neurobehavioral function. These findings provide additional information to professionals providing genetic counseling to, and assessment of, fra (X) families.

Entities:  

Mesh:

Year:  1993        PMID: 8488838      PMCID: PMC1682048     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90.

Authors:  R S Lipman; L Covi; A K Shapiro
Journal:  J Affect Disord       Date:  1979-03       Impact factor: 4.839

2.  Psychiatric disability in female carriers of the fragile X chromosome.

Authors:  A L Reiss; R J Hagerman; S Vinogradov; M Abrams; R J King
Journal:  Arch Gen Psychiatry       Date:  1988-01

3.  Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study.

Authors:  I L Cohen; G S Fisch; V Sudhalter; E G Wolf-Schein; D Hanson; R Hagerman; E C Jenkins; W T Brown
Journal:  Am J Ment Retard       Date:  1988-03

4.  Fragile X syndrome: growth, development, and intellectual function.

Authors:  L A Prouty; R C Rogers; R E Stevenson; J H Dean; K K Palmer; R J Simensen; G N Coston; C E Schwartz
Journal:  Am J Med Genet       Date:  1988 May-Jun

5.  Frequency and replication status of the fragile X, fra(X)(q27-28), in a pair of monozygotic twins of markedly differing intelligence.

Authors:  E Tuckerman; T Webb; S E Bundey
Journal:  J Med Genet       Date:  1985-04       Impact factor: 6.318

6.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

7.  Individual variation and specific cognitive deficits in the fra(X) syndrome.

Authors:  T M Theobald; D A Hay; C Judge
Journal:  Am J Med Genet       Date:  1987-09

8.  A profile of cognitive deficit in females from fragile X families.

Authors:  C M Miezejeski; E C Jenkins; A L Hill; K Wisniewski; J H French; W T Brown
Journal:  Neuropsychologia       Date:  1986       Impact factor: 3.139

9.  Proposed mechanism of inheritance and expression of the human fragile-X syndrome of mental retardation.

Authors:  C D Laird
Journal:  Genetics       Date:  1987-11       Impact factor: 4.562

10.  Prognostic validity of self-report and interview measures of personality disorder in depressed inpatients.

Authors:  B Pfohl; W Coryell; M Zimmerman; D Stangl
Journal:  J Clin Psychiatry       Date:  1987-12       Impact factor: 4.384

View more
  37 in total

1.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 2.  A review of fragile X premutation disorders: expanding the psychiatric perspective.

Authors:  James A Bourgeois; Sarah M Coffey; Susan M Rivera; David Hessl; Louise W Gane; Flora Tassone; Claudia Greco; Brenda Finucane; Lawrence Nelson; Elizabeth Berry-Kravis; Jim Grigsby; Paul J Hagerman; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2009-05-05       Impact factor: 4.384

3.  Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Deepa Kapoor; Kuldeep Singh; Chandra Vati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  RS46(DXS548) genotyping of reproductive cells: approaching preimplantation testing of the fragile-X syndrome.

Authors:  J C Dreesen; J P Geraedts; J C Dumoulin; J L Evers; M H Pieters
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

5.  Mental status of females with an FMR1 gene full mutation.

Authors:  B B de Vries; A M Wiegers; A P Smits; S Mohkamsing; H J Duivenvoorden; J P Fryns; L M Curfs; D J Halley; B A Oostra; A M van den Ouweland; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

6.  Social functioning among girls with fragile X or Turner syndrome and their sisters.

Authors:  M M Mazzocco; T Baumgardner; L S Freund; A L Reiss
Journal:  J Autism Dev Disord       Date:  1998-12

Review 7.  Fragile X syndrome. Molecular and clinical insights and treatment issues.

Authors:  R J Hagerman
Journal:  West J Med       Date:  1997-02

8.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

9.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.